Public Profile

Novartis BidCo AG

Novartis BidCo AG, a prominent subsidiary of Novartis AG, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Established in 1996, the company has made significant strides in the pharmaceutical industry, focusing on innovative medicines and advanced therapies. Specialising in areas such as oncology, cardiology, and immunology, Novartis BidCo AG is renowned for its commitment to research and development, delivering unique products that address unmet medical needs. The company has achieved notable market positioning, consistently ranking among the top global pharmaceutical firms. With a portfolio that includes groundbreaking treatments and a dedication to improving patient outcomes, Novartis BidCo AG continues to lead in the healthcare sector, driving advancements that shape the future of medicine.

DitchCarbon Score

How does Novartis BidCo AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

48

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Novartis BidCo AG's score of 48 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Novartis BidCo AG's reported carbon emissions

Novartis BidCo AG, headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data or specific reduction targets. As a leading player in the pharmaceutical industry, Novartis is expected to align with global climate commitments and industry standards. While no specific emissions figures or reduction initiatives are provided, the company is likely to be engaged in efforts to address climate change and reduce its carbon footprint in line with broader industry trends. Further details on their climate commitments or initiatives may be available in future disclosures.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Novartis BidCo AG's primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Novartis BidCo AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Novartis BidCo AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers